No Treatment Added

OTHER6 trials

Sponsors

Forest Laboratories, Azienda Ospedaliero-Universitaria di Modena, University of Nove de Julho, Meyer Children's Hospital IRCCS, Prairie View A&M University

Conditions

Convergence InsufficiencyFibromyalgiaObesity (Disorder)Ovarian ReserveShort Bowel Syndrome (SBS)White Spot Lesions

Phase 2

Extended LH Administration

Not yet recruitingNCT06883890

Azienda Ospedaliero-Universitaria di ModenaOvarian Reserve

Start: 2025-03-17End: 2026-09-01Target: 84Updated: 2025-03-19

Phase 3

Study of Milnacipran Added to Pregabalin for Treatment of Fibromyalgia

CompletedNCT00797797

Forest LaboratoriesFibromyalgia

Start: 2008-11-30End: 2010-01-31Updated: 2011-02-16

Unknown Phase

Effect of Oculomotor Therapy in Individuals With Convergence Insufficiency

Not yet recruitingNCT07036263

University of Nove de JulhoConvergence Insufficiency

Start: 2025-08-01End: 2025-12-30Target: 70Updated: 2025-06-25

TED_ORG: Study on Short Bowel Syndrome

RecruitingNCT07400783

Meyer Children's Hospital IRCCSShort Bowel Syndrome (SBS)

Start: 2024-10-30End: 2026-10-01Target: 50Updated: 2026-02-10

Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals.

Active, not recruitingNCT07505212

Prairie View A&M UniversityObesity (Disorder)

Start: 2026-04-14End: 2027-05-14Target: 20Updated: 2026-09-16

The Effect of Nano Chitosan Surface Coating on White Spot Lesions Development in Clear Aligner Therapy Patients

Active, not recruitingNCT07715552

Jordan University of Science and TechnologyWhite Spot Lesions

Start: 2025-10-12End: 2026-10-29Updated: 2026-07-20

Related Papers

Effect of Oculomotor Therapy on Convergence Insufficiency and Postural Control: Protocol for a Randomized Clinical Trial

Journal of Advances in Medicine and Medical Research2025-09-01